Elzbieta Janda studied Molecular Biology at Jagiellonian University in Cracow, Poland, and earned her PhD in Biochemistry from the Research Institute of Molecular Pathology in Vienna in 2002. Her postdoctoral work at UMG included collaboration with the Imperial Cancer Research Foundation in London and further specialization in signal transduction.